Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-03-13
2007-03-13
Campell, Bruce R. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C424S184100, C424S209100, C424S210100, C514S002600
Reexamination Certificate
active
10105232
ABSTRACT:
Peptides of influenza virus hemagglutinin protein andPlasmodium falciparummalaria antigen, antibodies specific for the peptides, influenza vaccines, malaria vaccines and methods of stimulating the immune response of a subject to produce antibodies to influenza virus or malaria are disclosed. Also disclosed are methods for formulating vaccines for influenza virus.
REFERENCES:
patent: 5104854 (1992-04-01), Schlesinger et al.
patent: 5231167 (1993-07-01), Zanetti et al.
patent: WO 00/18351 (2000-04-01), None
NCBI accession# gi 75059.
Brumeanu et al., J of Virology 1997 vol. 72 (7), pp. 5473-5480.
Gao et al., Identification and characterization of T helper epitopes in the nucleoprotein of influenza A virus. J Immunol 1989 vol. 143, pp. 3007-3014.
Bucher, D et al., M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies. J Virol. Sep. 1989; 63(9): 3622-3633.
Brown, L. R. et al., “Recognition of the influenza hemagglutinin by Class II MHC-restricted T lymphocytes and antibodies,”Journal of Immunology,Oct. 15, 1991, pp. 2677-2684, vol. 147, No. 8, American Association of Immunologists, USA, XP002371257, ISSN: 0022-1767.
Atassi, M. Z. et al., “A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: Antibody and T cell activity to several influenza hemagglutinin synthetic sites,”Immunological Communications,1984, pp. 539-551, vol. 13, No. 6, Marcel Dekker, Inc., XP009062995, ISSN: 0090-0877.
Carr, C. M. et al., “A spring-loaded mechanism for the conformational change of influenza hemagglutinin,”Cell,May 21, 1993, pp. 823-832, vol. 73, Cell Press, XP002059698, ISSN: 0092-8674.
Ben-Yedidia, T. et al., “Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection,”International Immunology,1999, pp. 1043-1051, XP000914818, ISSN: 0953-8178.
Schenk, S. et al., “Four recombinant isoforms ofCor a1, the major allergen of hazel pollen, show different reactivities with allergen-specific T-lymphocyte clones,”European Journal of Biochemistry,1994, pp. 717-722, vol. 224, XP002371408, ISSN: 0014-2956.
Orlando, C. et al., “A monoclonal antibody directed against the catalytic site ofBacillus anthracisadenylyl cyclase identifies a novel mammalian brain catalytic subunit,”Biochemistry,1992, pp. 3215-3222, vol. 31, American Chemical Society, XP002371438, ISSN: 0006-2960.
Andrew D. Pannifer, et al. “Crystal structure of the anthrax lethal factor,”Nature ,vol. 414, p. 229-233, (Nov. 2001).
Ping Zhao, et al. “Neutralizing monoclonal antibody against Anthrax lethal factor Inhibits Intoxication in a mouse model,”Human Antibodies,vol. 12, p. 129-135, (2003).
Ya Ping Shi, et al., “Immunogenicity andin vitroprotective efficacy of a recombinant multistagePlasmodium falciparumcandidate vaccine,”Proc. Natl. Acad. Sci.,vol. 96, pp. 1615-1620, (Feb. 1999).
Toby C. Rodman, et al., “Human Immunodeficiency Virus (HIV) Tat-reactive Antibodies Present in Normal HIV-negative Sera and Depleted in HIV-positive Sera. Identification of the Epitope,” vol. 175, pp. 1247-1253, (May 1992).
Database Medline on STN, National Library of Medicine, (Bethesda, MD, USA), No. 89028479, Bogoch et al.:In vitro production of the general transformation antibody related to survival in human cancer patients; antimalignin antibody;Abstract, Cancer Detection and Prevention, 1988, vol. 12, Nos. 1-6, pp. 313-320.
Bogoch Elenore S.
Bogoch Samuel
Campell Bruce R.
Hill Myron G.
Kenyon & Kenyon LLP
LandOfFree
Replikin peptides in rapid replication of glioma cells and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replikin peptides in rapid replication of glioma cells and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replikin peptides in rapid replication of glioma cells and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3806426